Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
April 16, 2026
Key Takeaways: Read also: Oil Sinks ~5%, Dow Jumps 600+ as Trump Halts Iran Strike Pfizer keeps expanding its GLP-1 portfolio in China through its second licensing deal in just a few months Ecnoglutide is a once-weekly injection already approved in China, with a weight management application currently under review Competition in the GLP-1 space is heating up fast, with heavyweights like Novo Nordisk and Eli Lilly already leading the pack Ecnoglutide belongs to a class of drugs known as GLP-1 receptor agonists, the same category as Novo Nordisk's Ozempic and Eli Lilly's Mounjaro
Of note, almost 15% of patients were lost to follow-up in both groups ( p = 0.7, data not shown)
Did it help you lose weight or better control your blood sugar
US$ 24.86
US$ 21.06
US$ 27.21
US$ 21.08
US$ 23.85
US$ 23.71
US$ 21.39
US$ 23.77
US$ 28.82
US$ 21.32
US$ 24.13
US$ 23.66
US$ 27.54
US$ 28.69
US$ 24.59
US$ 27.34
